PPARGC1A and chronic obstructive pulmonary disease: Similar findings were also observed in lung tissue from COPD patients at different disease stages, ranging from increased PPARGC1A abundance in mild or ex-smoking COPD patients to decreased abundance in moderate and severe COPD lung tissue (Hoffmann et al., 2013; Li et al., 2010).